GEN Exclusives

More »

GEN News Highlights

More »
May 15, 2009

Odyssey Thera to Help Mitsubishi Tanabe Pharma with Preclinical Research

  • Odyssey Thera will analyze drug candidates from a number of preclinical programs for Mitsubishi Tanabe Pharma. Odyssey Thera will apply its patented protein-fragment complementation assay, high-context screening infrastructure, institutional knowledge, and data analysis strategies in the collaboration to yield insights related to drug selectivity, safety, and mechanisms of action.

    Odyssey also reports the issuance of a Japanese patent entitled, “Protein fragment complementation assays for the detection of biological or drug interactions.”



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Stopping Research Fraud

What is the best approach to curbing scientific misconduct and outright fraud?